HK1045531B - 具有改進溶解性能的新的lhrh-拮抗劑 - Google Patents

具有改進溶解性能的新的lhrh-拮抗劑

Info

Publication number
HK1045531B
HK1045531B HK02107028.9A HK02107028A HK1045531B HK 1045531 B HK1045531 B HK 1045531B HK 02107028 A HK02107028 A HK 02107028A HK 1045531 B HK1045531 B HK 1045531B
Authority
HK
Hong Kong
Prior art keywords
improved solubility
solubility characteristics
lhrh antagonists
novel lhrh
novel
Prior art date
Application number
HK02107028.9A
Other languages
English (en)
Other versions
HK1045531A1 (en
Inventor
M‧伯恩德
B‧庫特斯徹
E‧岡瑟
P‧羅梅斯
T‧裡斯曼
T‧貝克爾斯
Original Assignee
贊塔裏斯有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 贊塔裏斯有限公司 filed Critical 贊塔裏斯有限公司
Publication of HK1045531A1 publication Critical patent/HK1045531A1/xx
Publication of HK1045531B publication Critical patent/HK1045531B/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/10—Peptides having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
    • A61P5/04—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin for decreasing, blocking or antagonising the activity of the hypothalamic hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/23—Luteinising hormone-releasing hormone [LHRH]; Related peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HK02107028.9A 1999-03-17 2002-09-26 具有改進溶解性能的新的lhrh-拮抗劑 HK1045531B (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19911771A DE19911771B4 (de) 1999-03-17 1999-03-17 LHRH-Antagonist, Verfahren zu seiner Herstellung und seiner Verwendung
PCT/EP2000/002165 WO2000055190A1 (de) 1999-03-17 2000-03-11 Neue lhrh-antagonisten mit verbesserten löslichkeitseigenschaften

Publications (2)

Publication Number Publication Date
HK1045531A1 HK1045531A1 (en) 2002-11-29
HK1045531B true HK1045531B (zh) 2005-05-20

Family

ID=7901213

Family Applications (1)

Application Number Title Priority Date Filing Date
HK02107028.9A HK1045531B (zh) 1999-03-17 2002-09-26 具有改進溶解性能的新的lhrh-拮抗劑

Country Status (33)

Country Link
US (3) US6627609B1 (zh)
EP (1) EP1163264B1 (zh)
JP (1) JP3801867B2 (zh)
KR (1) KR100569623B1 (zh)
CN (1) CN1185251C (zh)
AR (1) AR022970A1 (zh)
AT (1) ATE277077T1 (zh)
AU (1) AU759442B2 (zh)
BG (1) BG65283B1 (zh)
BR (1) BR0009472A (zh)
CA (1) CA2381461C (zh)
CO (1) CO5150192A1 (zh)
CZ (1) CZ301696B6 (zh)
DE (2) DE19911771B4 (zh)
DK (1) DK1163264T3 (zh)
ES (1) ES2225103T3 (zh)
HK (1) HK1045531B (zh)
HU (1) HU229672B1 (zh)
IL (3) IL145484A0 (zh)
MX (1) MXPA01010052A (zh)
NO (1) NO327753B1 (zh)
NZ (1) NZ514830A (zh)
PL (1) PL200647B1 (zh)
PT (1) PT1163264E (zh)
RU (1) RU2227145C2 (zh)
SI (2) SI1163264T1 (zh)
SK (1) SK287880B6 (zh)
TR (1) TR200103339T2 (zh)
TW (1) TWI243179B (zh)
UA (1) UA70997C2 (zh)
WO (1) WO2000055190A1 (zh)
YU (1) YU68702A (zh)
ZA (1) ZA200107753B (zh)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6828415B2 (en) * 1993-02-19 2004-12-07 Zentaris Gmbh Oligopeptide lyophilisate, their preparation and use
US5677184A (en) * 1994-04-19 1997-10-14 Takeda Chemical Industries, Ltd. CHO cells that express human LH-RH receptor
DE19911771B4 (de) * 1999-03-17 2006-03-30 Zentaris Gmbh LHRH-Antagonist, Verfahren zu seiner Herstellung und seiner Verwendung
US7005418B1 (en) 1999-09-23 2006-02-28 Zentaris Gmbh Method for the therapeutic management of extrauterine proliferation of endometrial tissue, chronic pelvic pain and fallopian tube obstruction
IL148185A0 (en) * 1999-09-23 2002-09-12 Zentaris Ag Method for the therapeutic management of extrauterine proliferation of endometrial tissue, chronic pelvic pain and fallopian tube obstruction
HUP0300222A3 (en) 2000-03-14 2004-08-30 Zentaris Gmbh Novel lhrh-antagonists, production and use thereof as medicament
DE10024451A1 (de) 2000-05-18 2001-11-29 Asta Medica Ag Pharmazeutische Darreichungsform für Peptide, Verfahren zu deren Herstellung und Verwendung
WO2002102401A1 (en) 2001-04-30 2002-12-27 Zentaris Gmbh Treatment of dementia and neurodegenerative diseases with intermediate doses of lhrh antagonists
SE0104462D0 (sv) * 2001-12-29 2001-12-29 Carlbiotech Ltd As Peptide purifcation (Peptidrening)
RS52966B (en) * 2002-09-27 2014-02-28 Zentaris Gmbh FORM OF THE THERAPEUTIC APPLICATION OF ACTIVE PEPTIDES WITH THE LONG TERM RELEASE OF THE ACTIVE INGREDIENT
CN100340572C (zh) * 2004-12-01 2007-10-03 中国人民解放军军事医学科学院毒物药物研究所 新的lhrh拮抗剂
CN101037472B (zh) * 2006-03-14 2013-03-27 中国人民解放军军事医学科学院毒物药物研究所 具有低组胺释放作用的促黄体生成素释放激素拮抗剂
EP1891964A1 (en) * 2006-08-08 2008-02-27 AEterna Zentaris GmbH Application of initial doses of LHRH analogues and maintenance doses of LHRH antagonists for the treatment of hormone-dependent cancers and corresponding pharmaceutical kits
CN101597321B (zh) * 2008-06-03 2013-04-24 中国人民解放军军事医学科学院毒物药物研究所 长效低组胺释放副作用的lhrh拮抗剂
WO2012050892A2 (en) * 2010-09-29 2012-04-19 Esperance Pharmaceuticals, Inc. Methods for stimulating, increasing or enhancing killing of a cell that expresses luteinizing hormone releasing hormone (lhrh) receptors
CN102584945A (zh) * 2012-02-09 2012-07-18 深圳翰宇药业股份有限公司 一种醋酸加尼瑞克的制备方法
CN103524599B (zh) * 2012-07-05 2016-04-20 中国人民解放军军事医学科学院毒物药物研究所 环肽lhrh拮抗剂衍生物及其药物用途
CN104231055A (zh) * 2013-06-18 2014-12-24 深圳翰宇药业股份有限公司 加尼瑞克前体以及由其制备醋酸加尼瑞克的方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4581169A (en) 1982-12-21 1986-04-08 Syntex (U.S.A.) Inc. Nona-peptide and deca-peptide analogs of LHRH, useful as LHRH antagonists
EP0145032B1 (en) 1983-08-16 1987-11-04 Akzo N.V. Lh- rh antagonists
US4800191A (en) * 1987-07-17 1989-01-24 Schally Andrew Victor LHRH antagonists
US5140009A (en) 1988-02-10 1992-08-18 Tap Pharmaceuticals, Inc. Octapeptide LHRH antagonists
US5300492A (en) * 1988-02-10 1994-04-05 Tap Pharmaceuticals LHRH analogs
EP0328090A3 (en) * 1988-02-10 1990-08-16 Abbott Laboratories Lhrh analogs
US5110904A (en) * 1989-08-07 1992-05-05 Abbott Laboratories Lhrh analogs
DE4117507A1 (de) 1991-05-24 1992-11-26 Schering Ag Verfahren zur herstellung von n(pfeil hoch)6(pfeil hoch)-substituierten lysin-derivaten
US5942493A (en) * 1995-11-28 1999-08-24 Asta Medica Aktiengesellschaft LH-RH antagonists having improved action
DE19544212A1 (de) * 1995-11-28 1997-06-05 Asta Medica Ag Neue LH-RH-Antagonisten mit verbesserter Wirkung
US6054432A (en) * 1996-09-12 2000-04-25 Asta Medica Aktiengesellschaft Means for treating prostate hypertrophy and prostate cancer
US5968895A (en) 1996-12-11 1999-10-19 Praecis Pharmaceuticals, Inc. Pharmaceutical formulations for sustained drug delivery
DE19911771B4 (de) * 1999-03-17 2006-03-30 Zentaris Gmbh LHRH-Antagonist, Verfahren zu seiner Herstellung und seiner Verwendung
US6586403B1 (en) * 2000-07-20 2003-07-01 Salpep Biotechnology, Inc. Treating allergic reactions and inflammatory responses with tri-and dipeptides
KR100876538B1 (ko) * 2000-08-17 2008-12-31 아에테르나 젠타리스 게엠베하 Ｌｈｒｈ 길항제의 염의 제조방법

Also Published As

Publication number Publication date
NO20014486D0 (no) 2001-09-14
JP2002543045A (ja) 2002-12-17
AR022970A1 (es) 2002-09-04
SI1163264T1 (en) 2004-12-31
CZ20013318A3 (cs) 2002-05-15
IL145484A0 (en) 2002-06-30
BG106008A (en) 2002-06-28
HUP0200363A2 (en) 2002-06-28
PL351792A1 (en) 2003-06-16
NZ514830A (en) 2003-05-30
PT1163264E (pt) 2004-12-31
JP3801867B2 (ja) 2006-07-26
TR200103339T2 (tr) 2002-04-22
NO327753B1 (no) 2009-09-14
SI1268522T1 (sl) 2009-02-28
WO2000055190A1 (de) 2000-09-21
HU229672B1 (en) 2014-04-28
DE50007905D1 (de) 2004-10-28
US7148195B2 (en) 2006-12-12
DE19911771B4 (de) 2006-03-30
BG65283B1 (bg) 2007-11-30
IL151647A (en) 2009-08-03
CN1348462A (zh) 2002-05-08
HUP0200363A3 (en) 2002-09-30
IL145484A (en) 2006-12-31
AU759442B2 (en) 2003-04-17
EP1163264A1 (de) 2001-12-19
CO5150192A1 (es) 2002-04-29
ATE277077T1 (de) 2004-10-15
ZA200107753B (en) 2002-05-13
AU3288700A (en) 2000-10-04
UA70997C2 (uk) 2004-11-15
US20040266695A1 (en) 2004-12-30
SK287880B6 (sk) 2012-02-03
BR0009472A (pt) 2001-11-27
NO20014486L (no) 2001-11-02
KR20020002482A (ko) 2002-01-09
CA2381461C (en) 2011-01-04
DE19911771A1 (de) 2000-09-28
PL200647B1 (pl) 2009-01-30
TWI243179B (en) 2005-11-11
ES2225103T3 (es) 2005-03-16
MXPA01010052A (es) 2003-07-14
CN1185251C (zh) 2005-01-19
US6627609B1 (en) 2003-09-30
CA2381461A1 (en) 2000-09-21
KR100569623B1 (ko) 2006-04-11
YU68702A (sh) 2006-01-16
CZ301696B6 (cs) 2010-05-26
HK1045531A1 (en) 2002-11-29
DK1163264T3 (da) 2004-12-06
US7732412B2 (en) 2010-06-08
RU2227145C2 (ru) 2004-04-20
EP1163264B1 (de) 2004-09-22
US20060281685A1 (en) 2006-12-14
SK13232001A3 (sk) 2002-05-09

Similar Documents

Publication Publication Date Title
EP1206262A4 (en) Y NEUROPEPTID ANTAGONISTS: SPIROISOQUINOLINONE DERIVATIVES
PL351792A1 (en) Novel lhrh antagonists with improved solubility characteristics
GB2352880B (en) Alternator
HK1043590A1 (zh) 毒蕈碱性拮抗物
HK1048307A1 (zh) 取代的雜環基-2h-苯並吡喃類化合物
GB9922942D0 (en) Catch
HUP0201201A2 (en) Endoparasiticidal agents
TW392548U (en) Improved socket structure
GB9911456D0 (en) Oligohydroxyl substituted 3-urea-benzofurane-and-pyridofurane-derivatives
TW403007U (en) Improved socket structure
PL352101A1 (en) Substituted phenylcyclohexanocarboxyamides
TW435204U (en) Marking-type injector
TW433433U (en) Improved lampstand
TW410560U (en) Improved pin structure
CA85738S (en) Cup
TW401794U (en) Improved cup
TW417922U (en) Catch structure
GB9923645D0 (en) Improved bollard
TW401901U (en) Improved socket structure
TW385836U (en) Pin structure
TW458186U (en) Improved form structure
GB9905027D0 (en) Waterer
GB9913624D0 (en) Game
GB9904243D0 (en) Game
HU9900182V0 (en) Parloor game

Legal Events

Date Code Title Description
CHRG Changes in the register
PE Patent expired

Effective date: 20200310